Novel pyrimido[1,2- a ]imidazole derivatives as potent Pks13-TE inhibitors: structure-based virtual screening and rational design
- 8 January 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (2) , 1066-1082
Abstract
Integrated virtual and biological screening guided the design and synthesis of 50 novel pyrimido[1,2- a ]imidazole derivatives, leading to the discovery of potent Pks13-TE inhibitor 34 (IC 50 = 0.23 μM).Keywords
Funding Information
- National Natural Science Foundation of China (22307024)
- National Natural Science Foundation of China (32394010)
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515011885)
This publication has 32 references indexed in Scilit:
- Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatmentEuropean Journal of Medicinal Chemistry, 2024
- Targeting polyketide synthase 13 for the treatment of tuberculosisEuropean Journal of Medicinal Chemistry, 2023
- 3-Methoxy-2-phenylimidazo[1,2-b]pyridazines highly active against Mycobacterium tuberculosis and Mycobacterium marinumEuropean Journal of Medicinal Chemistry, 2023
- Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leadsBioorganic Chemistry, 2021
- Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic moleculesEuropean Journal of Medicinal Chemistry, 2021
- hERG toxicity assessment: Useful guidelines for drug designEuropean Journal of Medicinal Chemistry, 2020
- Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosisBiomedicine & Pharmacotherapy, 2017
- An Antibacterial β‐Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid BiosynthesisAngewandte Chemie International Edition, 2017
- Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13Cell, 2017